Home > Annual Financials > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES Financial Statement Analysis
[BOM: 540737]

The Revenues of SHREE GANESH REMEDIES have increased by 0.63% YoY .
The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has decreased by -23.04 % YoY.
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Annual Financial Results
[BOM: 540737]

ConsolidatedMar2026
Mar2025
Mar2024
Mar2020
Mar2019
Revenues ₹109 Cr₹109 Cr₹126 Cr₹64 Cr₹35 Cr
Expenses ₹74 Cr₹69 Cr₹84 Cr₹52 Cr₹27 Cr
Operating Profit (Excl OI) ₹35 Cr₹39 Cr₹42 Cr₹13 Cr₹8.74 Cr
Other Income ₹3.03 Cr₹3.73 Cr₹3.07 Cr₹3.91 Cr₹1.17 Cr
Interest ₹3.56 Cr₹2.11 Cr₹0.61 Cr₹0.54 Cr₹0.20 Cr
Depreciation ₹10 Cr₹9.57 Cr₹6.11 Cr₹2.30 Cr₹1.04 Cr
Profit Before Tax ₹24 Cr₹31 Cr₹38 Cr₹14 Cr₹8.67 Cr
Profit After Tax ₹18 Cr₹23 Cr₹28 Cr₹10 Cr₹6.24 Cr
Consolidated Net Profit ₹18 Cr₹23 Cr₹28 Cr₹10 Cr₹6.24 Cr
Earnings Per Share (Rs)₹13.83₹17.97₹21.89₹11.67₹6.95
PAT Margin (%)16.0620.7121.7316.3617.66
ROE(%)11.5317.2634.2227.5518.43
ROCE(%)14.6319.5337.8134.7925.66
Total Debt/Equity(x)0.190.260.300.110.02

Key Financials

Market Cap : ₹ 878.3 Cr
Revenue (TTM) : ₹ 99.0 Cr
Net Profit(TTM) : ₹ 15.4 Cr
EPS (TTM) : ₹ 12.1
P/E (TTM) : 56.9

Industry Peers & Returns1W1M1Y
SHREE GANESH REMEDIES 1% 13.3% 22.5%
SUN PHARMACEUTICAL INDUSTRIES -1.8% -7% 14.3%
DIVIS LABORATORIES -3.4% 0.4% 58.4%
TORRENT PHARMACEUTICALS -2.7% -3.6% 36%
CIPLA -3.9% -4.7% -10.1%
DR REDDYS LABORATORIES 3% 6.1% -3.8%
MANKIND PHARMA 1.2% 4.4% 0.6%
LUPIN -2.7% -6.2% 3.5%
ZYDUS LIFESCIENCES -1.4% 0.1% 15.5%


SHREE GANESH REMEDIES Revenues
[BOM: 540737]

Y-o-Y

0.63 %

5 Yr CAGR

32.63 %

Years Revenues % Change
Mar2026 ₹109 Cr
0.63
Mar2025 ₹109 Cr
-13.74
Mar2024 ₹126 Cr
96.65
Mar2020 ₹64 Cr
81.29
Mar2019 ₹35 Cr -


SHREE GANESH REMEDIES Operating Profit
[BOM: 540737]

Y-o-Y

-10.69 %

5 Yr CAGR

41.47 %

Years Operating Profit % Change
Mar2026 ₹35 Cr
-10.69
Mar2025 ₹39 Cr
-6.20
Mar2024 ₹42 Cr
233.99
Mar2020 ₹13 Cr
43.17
Mar2019 ₹8.74 Cr -

Operating Margins
Y-o-Y

-11.27 %

5 Yr CAGR

6.66 %

Years Operating Margin% % Change
Mar2026 32.04%
-11.27
Mar2025 36.11%
8.73
Mar2024 33.21%
69.87
Mar2020 19.55%
-21.04
Mar2019 24.76% -

SHREE GANESH REMEDIES Profit After Tax
[BOM: 540737]

Y-o-Y

-23.01 %

5 Yr CAGR

29.91 %

Years Profit After Tax % Change
Mar2026 ₹18 Cr
-23.01
Mar2025 ₹23 Cr
-17.93
Mar2024 ₹28 Cr
168.44
Mar2020 ₹10 Cr
67.94
Mar2019 ₹6.24 Cr -

PAT Margins
Y-o-Y

-22.45 %

5 Yr CAGR

-2.35 %

Years PAT Margin(%) % Change
Mar2026 16.06 %
-22.45
Mar2025 20.71 %
-4.69
Mar2024 21.73 %
32.82
Mar2020 16.36 %
-7.36
Mar2019 17.66 % -

SHREE GANESH REMEDIES Earnings Per Share (EPS)
[BOM: 540737]

Y-o-Y

-23.04 %

5 Yr CAGR

18.77 %

Years EPS % Change
Mar2026 ₹14
-23.04
Mar2025 ₹18
-17.91
Mar2024 ₹22
87.57
Mar2020 ₹12
67.91
Mar2019 ₹6.95 -

SHREE GANESH REMEDIES Return on Capital Employed (ROCE)
[BOM: 540737]

Y-o-Y

-25.09 %

5 Yr CAGR

-13.10 %

Years ROCE % Change
Mar2026 14.63%
-25.09
Mar2025 19.53%
-48.35
Mar2024 37.81%
8.68
Mar2020 34.79%
35.58
Mar2019 25.66% -

SHREE GANESH REMEDIES Share Price vs Sensex

Current Share Price : ₹686.2
Current MarketCap: ₹ 878.3 Cr
Updated EOD on :Sep 30,2026

Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

1%

13.3%

22.5%

SENSEX

-3.1%

-6.2%

-11.7%

SHREE GANESH REMEDIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about SHREE GANESH REMEDIES Financials


How the annual revenues of SHREE GANESH REMEDIES have changed ?

The Revenues of SHREE GANESH REMEDIES have increased by 0.63% YoY .

How the Earnings per Share (EPS) of SHREE GANESH REMEDIES have changed?

The Earnings Per Share (EPS) of SHREE GANESH REMEDIES has decreased by -23.04 % YoY .